Early buyers will receive 10% customization on reports.
The cell counting market witnessed healthy growth during the last decade due to the growing stem cell research and rising incidences of cancer and AIDS, globally. However, high prices of advanced cell counting systems and reluctance among researchers to use advanced cell counting techniques are inhibiting the growth of this market to a certain extent.
In this report, this market is segmented on the basis of products, end users, and regions. On the basis of products, the market is categorized into instruments and consumables. The instruments market is further divided into four major segments, namely, spectrophotometers, flow cytometers, hematology analyzer, and cell counters. The spectrophotometers segment is bifurcated into single-mode readers and multi-mode readers; while the cell counters segment is bifurcated into automated cell counters; and hemocytometers and manual cell counters. The consumables segment is subdivided into reagents, assay kits, microplates, accessories, and other consumables. Furthermore, on the basis of end users, this market is categorized into hospitals and diagnostic laboratories, research institutions, pharmaceutical and biotechnology companies, and other end users.
In 2014, the spectrophotometers segment accounted for the largest share of the market. The introduction of enhanced data visualization and analysis software and growing out-of-pocket healthcare spending are boosting the growth of the spectrophotometers market.
On the basis of regions, North America accounted for the largest share of this market in 2014, followed by Europe, Asia-Pacific, and RoW. However, the Asia-Pacific region is the fastest-growing market for cell counting products primarily due to the rising aging population, increasing research collaborations, and increasing R&D and healthcare expenditure in this region. In addition, large-scale improvements in the healthcare infrastructure of countries such as China, Taiwan, and India are further driving the growth of this market.
Major players in the global market include Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.).
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
